COVID-19 reverses progress in fight against antimicrobial resistance in U.S. : hospitalization related infections grew 15% from 2019 to 2020 : media statement for immediate release: Tuesday, July 12, 2022

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  The COVID-19 pandemic pushed back years of progress made combating antimicrobial resistance (AR) in the United States. The report from the Centers for Disease Control and Prevention (CDC), COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022, concludes that the threat of antimicrobial-resistant infections is not only still present but has gotten worse—with resistant hospital-onset infections and deaths both increasing at least 15% during the first year of the pandemic.
• Subjects:
  Antimicrobial Stewardship COVID-19 Cross Infection Data Collection Drug Resistance, Microbial Hospitalization Pandemics Public Health Surveillance
• Document Type:
  Press Release
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:7995a0bd3f03db4e2b13f387e41157e9fd0c8d9f378bc1ab3e9e817844fd07a1
• Download URL:
  https://stacks.cdc.gov/view/cdc/119024/cdc_119024_DS1.pdf
• File Type:
  [PDF - 755.85 KB ]